KYNTRA BIO, INC. Other Comprehensive Income (Loss), Net of Tax
KYNTRA BIO, INC. (KYNB) reported Other Comprehensive Income (Loss), Net of Tax of $3.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- KYNTRA BIO, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was $3.00K.
- KYNTRA BIO, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was $289.00K, a 77.73% decline year-over-year.
- KYNTRA BIO, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $29.00K.
- KYNTRA BIO, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $2.58M.
- KYNTRA BIO, INC. other comprehensive income (loss), net of tax for fiscal 2025 was $3.55M, a 210.59% increase from fiscal 2024.
- KYNTRA BIO, INC. other comprehensive income (loss), net of tax for fiscal 2024 was $1.14M.
- KYNTRA BIO, INC. other comprehensive income (loss), net of tax for fiscal 2023 was -$1.16M.
- KYNTRA BIO, INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$1.56M, a 563.39% decline from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.00K 10-Q · filed 2026-08-13 | $292.00K 10-Q · filed 2026-08-13 | $321.00K derived: sum of 3 quarters · filed 2026-08-13 | $2.90M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $289.00K 10-Q · filed 2026-05-12 | $318.00K derived: sum of 2 quarters · filed 2026-05-12 | $2.90M derived: sum of 3 quarters · filed 2026-05-12 | $2.54M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.61M derived: sum of 2 quarters · filed 2026-03-16 | $2.25M derived: sum of 3 quarters · filed 2026-08-13 | $3.55M 10-K · filed 2026-03-16 |
| 2025-09-30 | $2.58M 10-Q · filed 2025-11-10 | $2.22M derived: sum of 2 quarters · filed 2026-08-13 | $3.52M 10-Q · filed 2025-11-10 | $3.42M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$360.00K 10-Q · filed 2026-08-13 | $938.00K 10-Q · filed 2026-08-13 | $834.00K derived: sum of 3 quarters · filed 2026-08-13 | -$985.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.30M 10-Q · filed 2026-05-12 | $1.19M derived: sum of 2 quarters · filed 2026-05-12 | -$625.00K derived: sum of 3 quarters · filed 2026-05-12 | $2.07M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$1.92M derived: sum of 2 quarters · filed 2026-03-16 | $775.00K derived: sum of 3 quarters · filed 2026-03-16 | $1.14M 10-K · filed 2026-03-16 |
| 2024-09-30 | -$1.82M 10-Q · filed 2025-11-10 | $879.00K derived: sum of 2 quarters · filed 2025-11-10 | $1.25M 10-Q · filed 2025-11-10 | $1.29M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $2.70M 10-Q · filed 2025-08-11 | $3.07M 10-Q · filed 2025-08-11 | $3.11M derived: sum of 3 quarters · filed 2025-08-11 | $2.44M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $368.00K 10-Q · filed 2025-05-12 | $416.00K derived: sum of 2 quarters · filed 2025-05-12 | -$257.00K derived: sum of 3 quarters · filed 2025-05-12 | -$1.94M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$625.00K derived: sum of 2 quarters · filed 2025-03-17 | -$2.31M derived: sum of 3 quarters · filed 2025-03-17 | -$1.16M 10-K · filed 2025-03-17 |
| 2023-09-30 | -$673.00K 10-Q · filed 2024-11-12 | -$2.35M derived: sum of 2 quarters · filed 2024-11-12 | -$1.20M 10-Q · filed 2024-11-12 | $423.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$1.68M 10-Q · filed 2024-08-06 | -$530.00K 10-Q · filed 2024-08-06 | $1.10M derived: sum of 3 quarters · filed 2024-08-06 | $680.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $1.15M 10-Q · filed 2024-05-06 | $2.78M derived: sum of 2 quarters · filed 2024-05-06 | $2.36M derived: sum of 3 quarters · filed 2024-05-06 | $1.94M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $1.21M derived: sum of 2 quarters · filed 2024-02-26 | $785.00K derived: sum of 3 quarters · filed 2024-02-26 | -$1.56M 10-K · filed 2024-02-26 |
| 2022-09-30 | -$416.00K 10-Q · filed 2023-11-06 | -$841.00K derived: sum of 2 quarters · filed 2023-11-06 | -$3.18M 10-Q · filed 2023-11-06 | -$3.19M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | -$425.00K 10-Q · filed 2023-08-07 | -$2.77M 10-Q · filed 2023-08-07 | -$2.77M derived: sum of 3 quarters · filed 2024-02-26 | -$2.36M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | -$2.34M 10-Q · filed 2023-05-08 | -$2.35M derived: sum of 2 quarters · filed 2024-02-26 | -$1.94M derived: sum of 3 quarters · filed 2024-02-26 | -$1.88M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $404.00K derived: sum of 2 quarters · filed 2024-02-26 | $461.00K derived: sum of 3 quarters · filed 2024-02-26 | $336.00K 10-K · filed 2024-02-26 |
| 2021-09-30 | $409.00K 10-Q · filed 2022-11-07 | $466.00K derived: sum of 2 quarters · filed 2022-11-07 | $341.00K 10-Q · filed 2022-11-07 | $98.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $57.00K 10-Q · filed 2022-08-08 | -$68.00K 10-Q · filed 2022-08-08 | -$311.00K derived: sum of 3 quarters · filed 2023-02-27 | -$3.01M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | -$125.00K 10-Q · filed 2022-05-09 | -$368.00K derived: sum of 2 quarters · filed 2023-02-27 | -$3.06M derived: sum of 3 quarters · filed 2023-02-27 | -$5.81M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | -$243.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$2.94M derived: sum of 2 quarters · filed 2023-02-27 | -$5.68M derived: sum of 3 quarters · filed 2023-02-27 | -$3.75M 10-K · filed 2023-02-27 |
| 2020-09-30 | -$2.69M 10-Q · filed 2021-11-09 | -$5.44M derived: sum of 2 quarters · filed 2021-11-09 | -$3.51M 10-Q · filed 2021-11-09 | -$4.03M derived: sum of 4 quarters · filed 2022-03-04 |
| 2020-06-30 | -$2.74M 10-Q · filed 2021-08-09 | -$814.00K 10-Q · filed 2021-08-09 | -$1.34M derived: sum of 3 quarters · filed 2022-03-04 | -$1.10M derived: sum of 4 quarters · filed 2022-03-04 |
| 2020-03-31 | $1.93M 10-Q · filed 2021-05-10 | $1.41M derived: sum of 2 quarters · filed 2022-03-04 | $1.65M derived: sum of 3 quarters · filed 2022-03-04 | $2.12M derived: sum of 4 quarters · filed 2022-03-04 |
| 2019-12-31 | -$523.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-04 | -$285.00K derived: sum of 2 quarters · filed 2022-03-04 | $190.00K derived: sum of 3 quarters · filed 2022-03-04 | $923.00K 10-K/A · filed 2022-03-04 |
| 2019-09-30 | $238.00K 10-Q · filed 2020-11-05 | $713.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.45M 10-Q · filed 2020-11-05 | $1.74M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $475.00K 10-Q · filed 2020-08-06 | $1.21M 10-Q · filed 2020-08-06 | $1.50M derived: sum of 3 quarters · filed 2021-03-01 | $1.54M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $733.00K 10-Q · filed 2020-05-07 | $1.02M derived: sum of 2 quarters · filed 2021-03-01 | $1.06M derived: sum of 3 quarters · filed 2021-03-01 | $2.07M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $289.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $330.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.34M derived: sum of 3 quarters · filed 2021-03-01 | $764.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $41.00K 10-Q · filed 2019-11-12 | $1.05M derived: sum of 2 quarters · filed 2019-11-12 | $475.00K 10-Q · filed 2019-11-12 | $289.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $1.01M 10-Q · filed 2019-08-08 | $434.00K 10-Q · filed 2019-08-08 | $248.00K derived: sum of 3 quarters · filed 2020-03-02 | $26.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$577.00K 10-Q · filed 2019-05-09 | -$763.00K derived: sum of 2 quarters · filed 2020-03-02 | -$985.00K derived: sum of 3 quarters · filed 2020-03-02 | -$1.35M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | -$186.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$408.00K derived: sum of 2 quarters · filed 2020-03-02 | -$774.00K derived: sum of 3 quarters · filed 2020-03-02 | -$835.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | -$222.00K 10-Q · filed 2018-11-08 | -$588.00K derived: sum of 2 quarters · filed 2018-11-08 | -$649.00K 10-Q · filed 2018-11-08 | -$275.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | -$366.00K 10-Q · filed 2018-08-07 | -$427.00K 10-Q · filed 2018-08-07 | -$53.00K derived: sum of 3 quarters · filed 2019-02-27 | -$362.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | -$60.00K 10-Q · filed 2018-05-09 | $313.00K derived: sum of 2 quarters · filed 2019-02-27 | $4.00K derived: sum of 3 quarters · filed 2019-02-27 | $684.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $373.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $64.00K derived: sum of 2 quarters · filed 2019-02-27 | $744.00K derived: sum of 3 quarters · filed 2019-02-27 | $691.00K 10-K · filed 2019-02-27 |
| 2016-09-30 | -$309.00K 10-Q · filed 2017-11-08 | $371.00K derived: sum of 2 quarters · filed 2017-11-08 | $318.00K 10-Q · filed 2017-11-08 | $281.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $680.00K 10-Q · filed 2017-08-07 | $627.00K 10-Q · filed 2017-08-07 | $590.00K derived: sum of 3 quarters · filed 2018-02-27 | -$401.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$53.00K 10-Q · filed 2017-05-09 | -$90.00K derived: sum of 2 quarters · filed 2018-02-27 | -$1.08M derived: sum of 3 quarters · filed 2018-02-27 | -$966.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | -$37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$1.03M derived: sum of 2 quarters · filed 2018-02-27 | -$913.00K derived: sum of 3 quarters · filed 2018-02-27 | $1.50M 10-K · filed 2018-02-27 |
| 2015-09-30 | -$991.00K 10-Q · filed 2016-11-08 | -$876.00K derived: sum of 2 quarters · filed 2016-11-08 | $1.53M 10-Q · filed 2016-11-08 | $1.56M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $115.00K 10-Q · filed 2016-08-08 | $2.53M 10-Q · filed 2016-08-08 | $2.55M derived: sum of 3 quarters · filed 2017-03-01 | $3.51M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $2.41M 10-Q · filed 2016-05-09 | $2.44M derived: sum of 2 quarters · filed 2017-03-01 | $3.40M derived: sum of 3 quarters · filed 2017-03-01 | $3.30M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $984.00K derived: sum of 2 quarters · filed 2017-03-01 | $889.00K derived: sum of 3 quarters · filed 2017-03-01 | $359.00K 10-K · filed 2017-03-01 |
| 2014-09-30 | $956.00K 10-Q · filed 2015-11-12 | $861.00K derived: sum of 2 quarters · filed 2015-11-12 | $331.00K 10-Q · filed 2015-11-12 | |
| 2014-06-30 | -$95.00K 10-Q · filed 2015-08-13 | -$625.00K 10-Q · filed 2015-08-13 | ||
| 2014-03-31 | -$530.00K 10-Q · filed 2015-05-12 | |||
| 2013-12-31 | -$3.34M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |